.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Esmolol hydrochloride - Generic Drug Details

« Back to Dashboard
Esmolol hydrochloride is the generic ingredient in six branded drugs marketed by Hq Spclt Pharma, Aurobindo Pharma Ltd, West-ward Pharms Int, Luitpold Pharms Inc, Fresenius Kabi Usa, Mylan Institutional, and Baxter Hlthcare, and is included in seven NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has thirty-nine patent family members in twenty-five countries.

There are eight drug master file entries for esmolol hydrochloride. Ten suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: esmolol hydrochloride

Tradenames:6
Patents:6
Applicants:7
NDAs:7
Drug Master File Entries: see list8
Suppliers / Packaging: see list10
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: esmolol hydrochloride

Tentative approvals for ESMOLOL HYDROCHLORIDE

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE;INJECTION100MG/10ML
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
INJECTABLE;INJECTION019386-005Jan 27, 2003RXYes6,528,540*PED► subscribeY► subscribe
Baxter Hlthcare
BREVIBLOC
esmolol hydrochloride
INJECTABLE;INJECTION019386-007May 28, 2003DISCNNo6,310,094*PED► subscribeY► subscribe
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-002Apr 7, 2016RXYes6,310,094► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: esmolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
BREVIBLOC
esmolol hydrochloride
INJECTABLE;INJECTION019386-003Aug 15, 19884,387,103► subscribe
Baxter Hlthcare
BREVIBLOC IN PLASTIC CONTAINER
esmolol hydrochloride
INJECTABLE;INJECTION019386-004Feb 16, 20014,593,119*PED► subscribe
Baxter Hlthcare
BREVIBLOC
esmolol hydrochloride
INJECTABLE;INJECTION019386-006Feb 25, 20034,593,119*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: esmolol hydrochloride

Country Document Number Estimated Expiration
China1775207► subscribe
Czech Republic304290► subscribe
Portugal1368019► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc